Rationale and Safety Assessment of a Novel Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release, Intended for Long-Term Protection of the Vaginal Microbiome

Open Access

Peer-reviewed

Research Article

Hans Verstraelen ,

* E-mail: hans.verstraelen@ugent.be

Affiliation Department of Obstetrics & Gynaecology, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium
⨯
Chris Vervaet,

Affiliation Department of Pharmaceutics, Laboratory of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
⨯
Jean-Paul Remon

Affiliation Department of Pharmaceutics, Laboratory of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
⨯

Reader Comments (0)

Lactic acid
Is the Subject Area "Lactic acid" applicable to this article?

Thanks for your feedback.
Microbiome
Is the Subject Area "Microbiome" applicable to this article?

Thanks for your feedback.
Bacterial vaginosis
Is the Subject Area "Bacterial vaginosis" applicable to this article?

Thanks for your feedback.
Glycogens
Is the Subject Area "Glycogens" applicable to this article?

Thanks for your feedback.
Vagina
Is the Subject Area "Vagina" applicable to this article?

Thanks for your feedback.
Hemorrhage
Is the Subject Area "Hemorrhage" applicable to this article?

Thanks for your feedback.
Polymers
Is the Subject Area "Polymers" applicable to this article?

Thanks for your feedback.
Community ecology
Is the Subject Area "Community ecology" applicable to this article?

Thanks for your feedback.